FDA needs to quickly act against IRBs enabling risky fat stem cell clinics

alphabet-soup-819x1024-239x3001

Institutional review boards or IRBs are some of the biggest enablers of risky, unproven stem cell clinics. We often see statements on stem cell clinic websites to the effect that they have approvals from IRBs so the clinic firms must think that patients like to see that. Why would specific IRBs approve for-profit “experiments” by …

FDA needs to quickly act against IRBs enabling risky fat stem cell clinics Read More »